c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven

New Haven, Connecticut 06510

0 studies enrolling now · 3 studies all time

What they study most

CD33 Positive Acute Myelogenous Leukemia, Cancer of the Prostate, Nonmetastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Prostate Cancer

Studies at this site

• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) — Stopped early
• Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy — NO_LONGER_AVAILABLE